<![CDATA[Sanofi ]]>enghttp://www.nasdaqomx.comCopyright (c)2014 NASDAQ OMXhttp://blogs.law.harvard.edu/tech/rssNASDAQ OMX - http://www.nasdaqomx.com/onlineservices@nasdaqomx.com (NASDAQ OMX)onlineservices@nasdaqomx.com (NASDAQ OMX)10<![CDATA[Sanofi ]]>http://www.huginonline.com/France/SANOFI/logo.jpghttp://www.huginonline.com450160<![CDATA[Sanofi's New Basal Insulin Lantus® XR, Known as Toujeo® in the U.S. and Europe, Approved in Japan for the Treatment of Diabetes Mellitus]]>Fri, 3 Jul 2015 08:06:13 +0200http://cws.huginonline.com/S/152918/PR/201507/1933885_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1933885_5.htmlhttp://hugin.info/152918/R/1933885/696194.pdf<![CDATA[Sanofi Signs a Global Agreement with SUEZ environnement To Enhance Water and Waste Management ]]>Thu, 2 Jul 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201507/1933373_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201507/1933373_5.htmlhttp://hugin.info/152918/R/1933373/695890.pdf<![CDATA[FDA Advisory Committee Recommends Approval of Sanofi and Regeneron's Praluent® (alirocumab) Injection for Patients with Hypercholesterolemia]]>Wed, 10 Jun 2015 01:12:03 +0200http://cws.huginonline.com/S/152918/PR/201506/1927485_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201506/1927485_5.htmlhttp://hugin.info/152918/R/1927485/691897.pdf<![CDATA[Sanofi's Lyxumia® (lixisenatide) Demonstrated Cardiovascular Safety in People with Type 2 Diabetes and High CV Risk]]>Mon, 8 Jun 2015 18:16:00 +0200http://cws.huginonline.com/S/152918/PR/201506/1926874_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201506/1926874_5.htmlhttp://hugin.info/152918/R/1926874/691597.pdf<![CDATA[Sanofi Announces Positive Results for Toujeo® in Phase III Study Extension in Japanese People with Uncontrolled Diabetes]]>Sat, 6 Jun 2015 21:01:00 +0200http://cws.huginonline.com/S/152918/PR/201506/1926730_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201506/1926730_5.htmlhttp://hugin.info/152918/R/1926730/691494.pdf<![CDATA[Sanofi: FDA Grants Breakthrough Therapy Designation for Genzyme's Olipudase Alfa]]>Thu, 4 Jun 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201506/1926197_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201506/1926197_5.htmlhttp://hugin.info/152918/R/1926197/691202.pdf<![CDATA[Sanofi Hosts German Chancellor Angela Merkel at Frankfurt Site]]>Thu, 28 May 2015 12:30:00 +0200http://cws.huginonline.com/S/152918/PR/201505/1924322_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201505/1924322_5.htmlhttp://hugin.info/152918/R/1924322/690231.pdf<![CDATA[Sanofi Appoints Suresh Kumar to the Executive Committee and Executive Vice President, External Affairs ]]>Tue, 26 May 2015 14:30:00 +0200http://cws.huginonline.com/S/152918/PR/201505/1923832_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201505/1923832_5.htmlhttp://hugin.info/152918/R/1923832/689965.pdf<![CDATA[Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Studies with Sarilumab in Patients with Rheumatoid Arthritis]]>Thu, 21 May 2015 07:00:00 +0200http://cws.huginonline.com/S/152918/PR/201505/1922870_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201505/1922870_5.htmlhttp://hugin.info/152918/R/1922870/689453.pdf<![CDATA[Sanofi and Regeneron Announce Positive Pivotal Phase 2b Dupilumab Data in Asthma Presented at the American Thoracic Society 2015 International Conference]]>Mon, 18 May 2015 18:30:00 +0200http://cws.huginonline.com/S/152918/PR/201505/1922218_5.htmlSanofi http://cws.huginonline.com/S/152918/PR/201505/1922218_5.htmlhttp://hugin.info/152918/R/1922218/689054.pdf